Twist Bioscience Corporation (TWST) AI-Powered Stock Analysis
See how Twist Bioscience Corporation scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
TWST●NASDAQ
HealthcareMedical - Diagnostics & Research
$69.22
$4.71(6.37%)
U.S. Market opens in 54h 41m
Advertisement
Twist Bioscience Corporation (TWST)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerTwist Bioscience Corporation (TWST) Stock Overall Grade
Twist Bioscience Corporation’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Twist Bioscience Corporation's overall stock rating.
Forecast
AScore
81/100Financial Growth
A+Score
100/100Fundamental Growth
C+Score
56/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
B+Score
75/100Twist Bioscience Corporation (TWST) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 81/100 (A), reflecting high confidence in its potential. Financial Growth (100/100, A+) and Fundamental Growth (56/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), it shows competitive strength. Analyst Consensus (75/100,B+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Twist Bioscience Corporation stock grade, including financials, comparisons, and forecasts.